Elsayed S. Moubarak: Evaluating Established and Emerging Biomarkers in Hemophilia A and B Management
Elsayed S. Moubarak, Member of NEGIDA Corporation, Researcher at Research Medical Center, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I’m pleased to share that our recent review article has been published in ASIDE Internal Medicine.
In this narrative review, we explored established and emerging biomarkers in Hemophilia A and B, highlighting their diagnostic, prognostic, and therapeutic implications in the era of extended half-life therapies, non-factor treatments, and gene therapy.
The review discusses:
- FVIII/FIX activity assays and inhibitor testing
- Genotyping approaches
- Global hemostasis assays
- Pharmacokinetic-guided prophylaxis
- Novel inflammatory and angiogenic markers linked to arthropathy
I am honored to contribute as Second Author and Corresponding Author on this work.
Grateful to my co-authors for their collaboration and dedication.”
Title: Biomarkers in Hemophilia: Diagnostic, Prognostic, and Treatment-Selection Utility: A Narrative Review of the Literature
Authors: Dalia Atef Abouda, Elsayed S. Moubarak, Fatma ElBadrawy, Malak A. Hassan, Mohamed Mohsen Helal, Abdallah M. Ibrahim, Hassan H. Eladl, Mohammad Mahadin, Mohamed Elsaid
Read the Full Article on ASIDE Internal Medicine Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 22, 2026, 17:19Ralf Ludwig: Bridging Population Data and Immunology in Inflammatory Diseases
-
Apr 22, 2026, 17:15Giacomo Rossi: Genetic Study Reveals 10 Genes in Hyperemesis Gravidarum
-
Apr 22, 2026, 17:06Maura Boerio: Quantifying Barriers to Care in Vascular Ehlers-Danlos Syndrome
-
Apr 22, 2026, 17:05Kausik Ray։ Metabolically Healthy Obesity Is Being Re-Evaluated as a High-Risk Condition Needing Closer Attention
-
Apr 22, 2026, 16:58Baba-Jallah Epega: Sickle Cell Resilience Through Patient Voices and Clinical Insight
-
Apr 22, 2026, 16:44Francisco Chacón-Lozsán: Cytokine Storm Is Not Just Inflammation, It Is Organ Failure in Motion
-
Apr 22, 2026, 16:29CBTH 2026 Opens with First Workshop in Germany – European Hematology Association
-
Apr 22, 2026, 16:16Christopher Pittman: Superficial Venous Disease Needs Arterial-Level Follow-Up
-
Apr 22, 2026, 15:47Mohammed Alo: Being Fit Does Not Protect You from High LDL